Neuroleptic malignant syndrome variant in a patient receiving donepezil and olanzapine

Nature Clinical Practice Neurology

Volumn 4, Issue 3, 2008, Pages 170-174

  Warwick, Tanya C ^a   Moningi, Venkata ^b   Jami, Prasuna ^c   Lucas, Kristy ^b   Molokwu, Ogochukwu ^a   Moningi, Shalini ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; DANTROLENE; DONEPEZIL; OLANZAPINE;

AGED; ARTICLE; ASPIRATION PNEUMONIA; BLOOD ANALYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DEMENTIA; DISEASE DURATION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; EMERGENCY WARD; FATIGUE; HUMAN; LABORATORY TEST; LETHARGY; LUMBAR PUNCTURE; MALE; MUSCLE STIFFNESS; NEUROLEPTIC MALIGNANT SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REHYDRATION; SCHIZOAFFECTIVE PSYCHOSIS; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT; URINALYSIS; WEAKNESS;

AGED; BENZODIAZEPINES; CHOLINESTERASE INHIBITORS; HUMANS; INDANS; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PIPERIDINES; SEROTONIN UPTAKE INHIBITORS;

EID: 40549113685     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0728     Document Type: Article

References (9)

1. Pelonero A et al. (1998) Neuroleptic malignant syndrome: A review. Psychiatr Serv 49: 1163-1172
2. Bottoni TN (2002) Neuroleptic malignant syndrome: A brief review. Hosp Physician 38: 58-63
3. Rozzini L et al. (2004) Severe worsening of parkinsonism in Lewy body dementia due to donepezil. Neurology 63: 1543-1544
4. Bourke D and Druckenbrod RW (1998) Possible association between donepezil and worsening Parkinson's disease. Ann Pharmacother 32: 610-611
5. Morita S et al. (2004) A patient with probable dementia with Lewy bodies, who showed catatonia induced by donepezil: A case report [Japanese]. No To Shinkei 56: 881-884
6. Lee JW (2007) Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome. Ann Clin Psychiatry 119: 9-16
7. Hu S and Frucht S (2007) Emergency treatment of movement disorders. Curr Treat Options Neurol 9: 103-114
8. Trollor JN and Sachdev PS (1999) Electroconvulsive treatment of neuroleptic malignant syndrome: A review and report of cases. Aust N Z J Psychiatry 33: 650-659
9. Sato Y et al. (2004) Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease. J Neurol Neurosurg Psychiatry 75: 510-515